Bloodline Research and Supplements Group

Home  /  Evidence ledger  /  BPC-157 + TB-500

BPC-157 + TB-500

Two separate peptides · 15 + 7 amino acids

Not approved

A combination of two compounds, neither of which has controlled human efficacy data. Combining them does not produce evidence for the pair. This is worth stating plainly because the combination is often marketed as though it were a distinct, better-supported product.

Free, no obligation

Ask us anything

Every inquiry gets a real answer from a person. If what you're asking about isn't supported by evidence, we'll say so.

BPC-15715 aaTB-5007 aa
Components
2 separate peptides
BPC-157
15 residues
TB-500
7 residues
Studied as a pair
No

Schematic structure, not to scale. Beads represent amino acid residues along the backbone.

The theory behind it

In theory, the combination is designed to address tissue repair from two directions at once. One component driving blood vessel formation, the other driving cell migration into the wound bed. As reasoning it is coherent, and coherent reasoning is a fine place to start research. It is not a substitute for it: neither component has controlled human efficacy data, so the pairing has none either.

The detail, if you want it

What it is

A pairing of BPC-157 and a thymosin beta-4 fragment, usually sold under a brand or nickname rather than by its components. The rationale offered is that the two act on complementary aspects of tissue repair, angiogenesis and cell migration respectively.

Why the evidence does not add up

Each component individually lacks controlled human efficacy data. A combination of two things with no human evidence has no human evidence. More specifically: combination products are not separately studied, so even if data existed for each in isolation, it would not establish the safety, efficacy, or interaction profile of the pair. Effects of combinations are not the sum of their parts, and can differ in ways that are only discoverable by studying the combination.

On branded stack names

Marketing names for peptide combinations are not scientific designations and do not correspond to any studied formulation. If a product is sold under a nickname, the relevant question is what the components are, at what ratio, and what evidence exists for that specific pairing, which in this case is none.

Not sure whether this applies to you?

That is the question a consultation answers. A licensed physician reviews your situation and tells you what the evidence supports. Including when the honest answer is no.

See consultations

Also on the ledger